More children are surviving cancer because of improved diagnostic methods and targeted treatment, figures from Dutch cancer ...

Acalabrutinib–Venetoclax improves progression-free survival and reduces disease progression in untreated chronic lymphocytic ...

IN8bio is accelerating patient enrollment in the INB-100 program and expects to complete enrollment of the expansion cohort in 2025. The company’s FDA discussions confirmed that relapse-free survival ...

Improved diagnostics and treatments mean that the survival rate for children with cancer continues to increase, the ...

The five-year survival rate of children under 15 diagnosed with leukemia, which is a common form of cancer in childhood, stood at 88 percent. Children with a brain tumor showed a lower survival ...

A new international study has found that a simple tablet treatment could improve survival rates for people with chronic ...

IN8bio (INAB) presented Phase 1 data on its allogeneic gamma-delta T cell therapy, INB-100, at the 2025 Transplantation & Cellular Therapy, ...

In a 2021 study, researchers found that the most common cause of death among people with newly diagnosed CLL was: The survival rate for CLL is higher than many other types of leukemia and cancer.

Unrelated cord blood transplant demonstrated efficacy in patients with blood cancer after microcystic adnexal carcinoma.

The HKUMed research team then moved oral-ATO to the maintenance treatment of APL patients in first complete remission, resulting in a 90% five-year leukemia-free survival (LFS) rate and a 97% OS rate.

Very sick patients who get a bone marrow transplant at Medical University of South Carolina survive at a much higher rate ...